An observational study in HIV Infections, sponsored by Harvard School of Public Health (HSPH). Completed at 1 site in Botswana. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2011-10-07.
Sponsored by Harvard School of Public Health (HSPH) · Observational
The goals of this study are to:
determine the diarrheal rates, morbidity, mortality, and pathogens present among breast-fed infants born to HIV-infected mothers.
4,258 studies on the registry are indexed under HIV Infections; 240 are open to participants now.
This study's enrollment of 1,350 is above the median of 200 across 713 observational studies indexed under HIV Infections.
Browse HIV Infections studies →Harvard School of Public Health (HSPH) is the lead sponsor of 150 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Primary care clinic
For HIV-infected subjects:
Exclusion Criteria:
400 diarrheal specimens will suffice to determine the prevalence of specific pathogens in the region. Of these, 300 specimens will be collected from infants born to HIV infected mothers, and 100 specimens will be collected from infants born to HIV uninfected mothers.
Breast milk from HIV infected and HIV uninfected women who are breastfeeding is collected at 2 days, 2 weeks, 2 months, and 5 months post-partum. This breast milk will be compared for in vitro functional quality of immunoglobulins to selected diarrheal and respiratory pathogens.
OCCURRENCE OF SUSPECTED PNEUMONIA OR BLOODSTREAM INFECTION OVER FIRST TWO YEARS OF LIFE
Time frame: 24 months
This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Harvard School of Public Health (HSPH)